Neutralizing monoclonal antibodies directed against five antigenic sites on the spike (S) S1 glycopolypeptide of avian infectious bronchitis virus (IBV) were used to select neutralization-resistant variants of the virus. By comparing the nucleotide sequence of such variants with the sequence of the IBV parent strain, we located five antigenic sites on the amino acid sequence of the S1 glycopolypeptide. The variants had mutations within three regions corresponding to amino acid residues 24 to 61, 132 to 149 and 291 to 398 of the S1 glycopolypeptide. The location of three overlapping antigenic sites on the IBV spike protein was similar to the location of antigenic sites on the spike protein of other coronaviruses.
AirG. M.1979; Nucleotide sequence coding for the ‘signal peptide’ and N terminus of the hemagglutinin from an Asian (H2N2) strain of influenza virus. Virology 97:468–472
CavanaghD.1983a; Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides. Journal of General Virology 64:1787–1791
CavanaghD.,
DavisP. J.1986; Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells. Journal of General Virology 67:1443–1448
CavanaghD.,
DavisP. J.,
DarbyshireJ. H.,
PetersR. W.1986; Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. Journal of General Virology 67:1435–1442
CavanaghD.,
DavisP. J.,
MockettA. P. A.1988; Amino acids within hypervariable region 1 of avian coronavirus IBV (Massachusetts serotype) spike glycoprotein are associated with neutralization epitopes. Virus Research 11:141–150
CavanaghD.,
DavisP. J.,
CookJ. K. A.,
LID.,
KantA.,
KochG.1992; Location of the amino acid differences in the S1 spike glycoprotein subunit of closely related serotypes of infectious bronchitis virus. Avian Pathology (in press)
CorreaI.,
GebauerF.,
BullidoM. J.,
SuÑÉC.,
BaayM. F. D.,
ZwaagstraK. A.,
PosthumusW. P. A.,
LenstraJ. A.,
EnjuanesL.1990; Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. Journal of General Virology 71:271–279
DavelaarF. G.,
KouwenhovenB.,
BurgerA. C.1984; Occurrence and significance of infectious bronchitis virus variants in egg and broiler production in the Netherlands. Veterinary Quarterly 6:114–120
de BordeD. C.,
NaeveC. W.,
HerlocherM. L.,
MaassabH. F.1986; Resolution of a common RNA sequencing ambiguity by terminal deoxynucleotidyl transferase. Analytical Biochemistry 157:275–282
de GrootR. J.,
LuytjesW.,
HorzinekM. C.,
van der ZeijstB. A. M.,
SpaanW. J. M.,
LenstraJ. A.1987a; Evidence for a coiled-coil structure in the spike protein of coronaviruses. Journal of Molecular Biology 196:963–966
de GrootR. J.,
LenstraJ. A.,
LuytjesW.,
NiestersH. G. M.,
HorzinekM. C.,
van der ZeijstB. A. M.,
SpaanW. J. M.1987b; Sequence and structure of the coronavirus peplomer protein. In Coronaviruses pp 31–39 Edited by
LaiM. M. C.,
StohlmanS. A.
New York: Plenum Press;
DelmasB.,
RasschaertD.,
GodetM.,
GelfiJ.,
LaudeH.1990; Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S. Journal of General Virology 71:1313–1323
FlemingJ. O.,
TrousdaleM. D.,
El-ZaatariF. A. K.,
StohlmanS. A.,
WeinerL. P.1986; Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. Journal of Virology 58:869–875
GeysenH. M.,
MeloenR. H.,
BartelingS. J.1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proceedings of the National Academy of Sciences U.S.A 81:3998–4002
JacobsL.,
de GrootR. J.,
van der ZeijstB. A. M.,
HorzinekM. C.,
SpaanW. J. M.1987; The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV). Virus Research 8:363–371
KochG.,
KantA.1990; Antigenic domains on the peplomer of infectious bronchitis virus that are defined by neutralizing antibodies are dependent on glycosylation. In Coronaviruses and Their Diseases Edited by
CavanaghD.,
BrownT. D. K.
London: Plenum Press;
KochG.,
HartogL.,
KantA.,
van RoozelaarD. J.1990; Antigenic domains on the peplomer proteins of avian infectious bronchitis virus: correlation with biological function. Journal of General Virology 71:1929–1935
KustersJ. G.,
JagerE. J.,
LenstraJ. A.,
KochG.,
PosthumusW. P. A.,
MeloenR. H.,
van der ZeijstB. A. M.1989a; Analysis of an immunodominant region of avian coronavirus infectious bronchitis virus. Journal of Immunology 143:2692–2699
KustersJ. G.,
NiestersH. G. M.,
LenstraJ. A.,
HorzinekM. C.,
van der ZeustB. A. M.1989b; Phylogeny of antigenic variants of coronavirus IBV. Virology 169:217–221
LenstraJ. A.,
KustersJ. G.,
KochG.,
van der ZeijstB. A. M.1989; Antigenicity of the peplomer protein of infectious bronchitis virus. Molecular Immunology 1:7–15
MockettA. P. A.,
CavanaghD.,
BrownT. D. K.1984; Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41. Journal of General Virology 65:2281–2286
NiestersH. G. M.,
LenstraJ. A.,
SpaanW. J. M.,
ZijderveldA. J.,
Bleumink-PluymN. M. C.,
HongF.,
van ScharrenburgG. J. M.,
HorzinekM. C.,
van der ZeijstB. A. M.1986; The peplomer protein sequence of the M41 strain of coronavirus IBV and its comparison with Beaudette strains. Virus Research 5:253–263
NiestersH. G. M.,
Bleumink-PluymN. M. C.,
OsterhausA. D. M. E.,
HorzinekM. C.,
van der ZeijstB. A. M.1987; Epitopes on the peplomer protein of infectious bronchitis virus strain M41 as defined by monoclonal antibodies. Virology 161:511–519
ParkerM. D.,
YooD.,
CoxG. J.,
BabiukL. A.1990; Primary structure of the S peplomer gene of bovine coronavirus and surface expression in insect cells. Journal of General Virology 71:263–270
ParkerS. E.,
GallagherT. M.,
BuchmeierM. J.1989; Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173:664–673
SangerF.,
NicklenS.,
CoulsonA. R.1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
ThomasA. A. M.,
WoortmeijerR. J.,
PuijkW.,
BartelingS. J.1988; Antigenic sites on foot-and-mouth disease virus type A10. Journal of Virology 62:2782–2789
WegeH.,
WinterJ.,
MeyermannR.1988; The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. Journal of General Virology 69:87–98